MOH — authorised 21 September 2000
- Marketing authorisation holder: SALIX PHARMS
- Status: likely_approved
MOH authorised Osmoprep on 21 September 2000
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. MOH authorised it on 21 September 2000.
SALIX PHARMS holds the UAE marketing authorisation.